Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 14.11.19 in Vol 5, No 4 (2019): Oct-Dec

This paper is in the following e-collection/theme issue:

Works citing "Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study"

According to Crossref, the following articles are citing this article (DOI 10.2196/12016):

(note that this is only a small subset of citations)

  1. Dos Santos G, Nguyen B, Damaso S, Godderis L, Martínez-Gómez X, Eckermann T, Loos H, Salamanca de la Cueva I, Shende V, Schmidt AC, Yeakey A. Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. Drug Safety 2020;43(3):265
    CrossRef
  2. Dos Santos G. Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives. Human Vaccines & Immunotherapeutics 2019;15(11):2624
    CrossRef
  3. Dos Santos G, Shende V, Damaso S, Yeakey A. Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis. Advances in Therapy 2019;36(12):3340
    CrossRef